Deutsche Bank Aktiengesellschaft reiterated their buy rating on shares of Johnson Matthey (LON:JMAT – Free Report) in a research report sent to investors on Monday morning, Marketbeat.com reports. They currently have a GBX 2,400 ($30.45) price objective on the stock.
Other analysts also recently issued research reports about the stock. Jefferies Financial Group reissued a buy rating and set a GBX 2,100 ($26.64) price objective on shares of Johnson Matthey in a report on Wednesday, March 20th. Numis Securities reissued a buy rating and set a GBX 2,200 ($27.91) price objective on shares of Johnson Matthey in a report on Wednesday, March 20th. Finally, Berenberg Bank reissued a hold rating and set a GBX 1,800 ($22.83) price objective on shares of Johnson Matthey in a report on Tuesday, June 11th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, Johnson Matthey has a consensus rating of Moderate Buy and a consensus price target of GBX 1,993.33 ($25.29).
Check Out Our Latest Analysis on Johnson Matthey
Johnson Matthey Stock Down 0.6 %
Johnson Matthey Increases Dividend
The business also recently declared a dividend, which will be paid on Tuesday, August 6th. Shareholders of record on Thursday, June 6th will be paid a dividend of GBX 55 ($0.70) per share. The ex-dividend date of this dividend is Thursday, June 6th. This represents a yield of 3.04%. This is an increase from Johnson Matthey’s previous dividend of $22.00. Johnson Matthey’s dividend payout ratio (DPR) is currently 13,050.85%.
Insiders Place Their Bets
In related news, insider Stephen Oxley purchased 24 shares of the business’s stock in a transaction on Wednesday, June 19th. The shares were bought at an average price of GBX 1,547 ($19.62) per share, with a total value of £371.28 ($470.99). In other Johnson Matthey news, insider Liam Condon acquired 18 shares of the company’s stock in a transaction dated Wednesday, May 15th. The stock was bought at an average price of GBX 1,871 ($23.73) per share, with a total value of £336.78 ($427.22). Also, insider Stephen Oxley acquired 24 shares of the company’s stock in a transaction dated Wednesday, June 19th. The stock was acquired at an average cost of GBX 1,547 ($19.62) per share, with a total value of £371.28 ($470.99). Insiders have purchased a total of 66 shares of company stock valued at $113,214 over the last quarter. Company insiders own 0.57% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
- Five stocks we like better than Johnson Matthey
- Profitably Trade Stocks at 52-Week Highs
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Are Penny Stocks a Good Fit for Your Portfolio?
- Progress Software Stock Back in the Green After Beating Forecasts
- Energy and Oil Stocks Explained
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.